Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist Awards

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Datta Pawde | Pharmaceutical Analysis | Best Researcher Award

Published-on by Indian Scientist Awards

Dr. Datta Pawde | Pharmaceutical Analysis | Best Researcher Award

Department of Pharmaceutical Sciences,  India

Dr. Datta Maroti Pawde is an academic and researcher in Pharmaceutics, currently serving as an Assistant Professor in Pharmaceutical Sciences at a central university in India. He holds doctoral and postgraduate training from nationally reputed institutes and has teaching experience at a leading deemed university. His research interests focus on advanced drug delivery systems, formulation development, and pharmaceutical technology. He has received prestigious fellowships, international research recognition, and academic honors, reflecting his strong contribution to pharmaceutical education and research.

Citation Metrics (Scopus)

600
500
30
20
10
0

Citations
512

Documents
27

h-index
12

Citations

Documents

h-index

Featured Publications

Srinivasaprabhu Natarajan | Pharmaceutical Management | Research Excellence Award

Published-on by Indian Scientist Awards

Dr. Srinivasaprabhu Natarajan | Pharmaceutical Management | Research Excellence Award

Delvin Formulations | India

An accomplished sales and market expansion professional with strong expertise in B2B strategy, CRM-driven growth, and customer relationship management. Holds advanced academic training in biotechnology and biomedical engineering with a focus on pharmaceutical marketing. Demonstrated experience across leading pharmaceutical organizations, driving territory growth, market penetration, pricing strategy, and sales training initiatives. Research interests include pharmaceutical marketing analytics, CRM optimization, sales forecasting, and market expansion models. Recipient of multiple performance and retention awards, consistently contributing to sustainable business growth and organizational excellence.

Citation Metrics (Scopus)

150
100
50
5
0

Citations
139

h-index
3

Documents
3

Citations

h-index

Documents

Featured Publications


Bio-electrokinetic remediation of crude oil contaminated soil enhanced by bacterial biosurfactant


– Journal of Hazardous Materials · Article · Cited by 93 · 2021


Synthesis of silver nanoparticles from marine bacteria and evaluation of antimicrobial, antifungal and cytotoxic effects


– Journal of King Saud University – Science · Article · Cited by 27 · 2024

All links point to open-access DOI or public repository versions; citation counts may vary across databases.

Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist Awards

Assoc. Prof. Dr. Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Shreeyash Institute of Pharmaceutical Education and Research | India

Dr. Sachin Ashok Dhawale is a dedicated researcher in medicinal chemistry and pharmaceutical sciences, recognized for his contributions to drug design, molecular modeling, and synthetic chemistry. With a strong academic foundation including a PhD in Pharmacy, M.Pharm in Pharmaceutical Chemistry, and a B.Pharm degree, he has built extensive experience across academic and research environments, serving in teaching positions and contributing to funded research projects as a JRF and SRF under national scientific bodies. His scientific impact is reflected in 136 citations, an h-index of 6, and an i10-index of 4, supported by more than 25 Scopus-indexed publications, several as first or corresponding author, and cumulative impact exceeding 50. His research spans anticancer agents, antimicrobial molecules, molecular docking, natural product-based therapeutics, ADMET studies, and computational chemistry approaches. He has guided multiple undergraduate and postgraduate research projects, presented papers at national and international conferences, and published a specialized book on computer-aided drug design. His work has earned several recognitions including first-prize awards at competitive scientific events and fellowship support from national and state agencies. With expertise in advanced cheminformatics tools and synthetic techniques, he continues to contribute to innovative therapeutic discovery aimed at improving human health.

Profile: Google Scholar | Orcid

Featured Publications

Gandla, K., Islam, F., Zehravi, M., Karunakaran, A., Sharma, I., Haque, M. A., … Dhawale, S. A. (2023). Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon, 9(9).

Singu, P. S., Kanugala, S., Dhawale, S. A., Kumar, C. G., & Kumbhare, R. M. (2020). Synthesis and pharmacological evaluation of some amide functionalized 1H-benzo[d]imidazole-2-thiol derivatives as antimicrobial agents. ChemistrySelect, 5(1), 117–123.

Dube, P. N., Sakle, N. S., Dhawale, S. A., More, S. A., & Mokale, S. N. (2019). Synthesis, biological investigation and docking study of novel chromen derivatives as anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 13.

Gawai, A. A., Kharat, A. R., Chorge, S. S., & Dhawale, S. A. (2023). Green synthesis of silver nanoparticles mediated Azadirachta indica extract and study of their characterization, molecular docking, and antibacterial activity. Journal of Molecular Recognition, 36(10), e3051.

Suryawanshi, R. M., Shimpi, R. B., Muralidharan, V., Nemade, L. S., Gurugubelli, S., … Dhawale, S. A. (2025). ADME, toxicity, molecular docking, molecular dynamics, glucokinase activation, DPP-IV, α-amylase, and α-glucosidase inhibition assays of mangiferin and friedelin for antidiabetic potential. Chemistry & Biodiversity, 22(5), e202402738.

Abdus Samad | Pharmacy | Outstanding Scientist Award

Published-on by Indian Scientist Awards

Dr. Abdus Samad | Pharmacy | Outstanding Scientist Award

Post Graduate Institute of Medical Education & Research, Chandigarh | India

Dr. Sahima Tabasum is an emerging Environmental Science researcher with expertise in nanomaterials, water purification, photocatalysis, and environmental remediation, supported by an h-index of 4, over 48 citations, and 10 indexed documents. She holds a Ph.D. in Environmental Sciences, where she focused on nano-structural modification of g-C3N4-based composites for pesticide mineralization and the development of continuous photocatalytic reactor systems. Her multidisciplinary training includes advanced material synthesis, wastewater treatment technologies, solid waste management, and water quality monitoring. Dr. Tabasum has gained research experience through academic and international environmental programs, contributing to nanomaterial-based pollutant degradation, biochar fabrication, membrane technologies, microplastic treatment, and molecularly imprinted polymer (MIP) systems for emerging contaminants such as PFAS, ammonia, and heavy metals. Her research interests span photocatalysis, polymer membranes, CO₂ conversion, energy generation, nanomaterial–pollutant interactions, and sustainable environmental technologies. She has been recognized with distinctions for poster presentations, project excellence, and prestigious Young Scientist–International Travel Support, along with contributions to conferences, workshops, and global sustainability dialogues. With active roles as a reviewer and editorial board member for reputed journals, she continues to advance sustainable materials, green catalytic systems, and innovative solutions for environmental challenges.

Profile: Google Scholar

Featured Publications

Samad, A., Sultana, Y., & Aqil, M. (2007). Liposomal drug delivery systems: An update review. Current Drug Delivery, 4(4), 297–305.
(Cited by: 1310)

Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010). Strategy for effective brain drug delivery. European Journal of Pharmaceutical Sciences, 40(5), 385–403.
(Cited by: 557)

Samad, A., Alam, M. I., & Saxena, K. (2009). Dendrimers: A class of polymers in nanotechnology for the delivery of active pharmaceuticals. Current Pharmaceutical Design, 15(25), 2958–2969.
(Cited by: 129)

Beg, S., Samad, A., Alam, M. I., & Nazish, I. (2011). Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS & Neurological Disorders – Drug Targets, 10(6), 693–702.
(Cited by: 84)

Samad, A., Shams, M. S., Ullah, Z., Wais, M., Nazish, I., Sultana, Y., & Aqil, M. (2009). Status of herbal medicines in the treatment of diabetes: A review. Current Diabetes Reviews, 5(2), 102–111.
(Cited by: 78)